Bonten, Erik J.
St. Jude Children's Research Hospital
15 papers on CoChat
Most cited papers
- Verified
Characterization of human lysosomal neuraminidase defines the molecular basis of the metabolic storage disorder sialidosis.
Bonten, E., van der Spoel, A., Fornerod, M., Grosveld, G., & d'Azzo, A. (1996) · Genes & Development
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 313
- Verified
Neuraminidase 1 Is a Negative Regulator of Lysosomal Exocytosis
Yogalingam, G., Bonten, E. J., van de Vlekkert, D., Hu, H., Moshiach, S., Connell, S. A., & d'Azzo, A. (2008) · Developmental Cell
Cellular transport and secretionGlycosylation and Glycoproteins Research
Cited by 185
- Verified
NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells
Paugh, S. W., Bonten, E. J., Savic, D., Ramsey, L. B., Thierfelder, W. E., Gurung, P., Malireddi, R. K. S., Actis, M., Mayasundari, A., Min, J., et al. (2015) · Nature Genetics
Acute Lymphoblastic Leukemia researchInflammasome and immune disorders
Cited by 164
- Verified
Human lysosomal protective protein has cathepsin A-like activity distinct from its protective function
Galjart, N. J., Morreau, H., Willemsen, R., Gillemans, N., Bonten, E. J., & d'Azzo, A. (1991) · Journal of Biological Chemistry
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 158
- Verified
Lysosomal multienzyme complex: pros and cons of working together
Bonten, E. J., Annunziata, I., & d’Azzo, A. (2014) · Cellular and Molecular Life Sciences
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 117
- Verified
Three-dimensional structure of the human protective protein: structure of the precursor form suggests a complex activation mechanism
Rudenko, G., Bonten, E., d'Azzo, A., & GJ Hol, W. (1995) · Structure
Enzyme Structure and FunctionLysosomal Storage Disorders Research
Cited by 97
- Verified
Heterodimerization of the Sialidase NEU1 with the Chaperone Protective Protein/Cathepsin A Prevents Its Premature Oligomerization
Bonten, E. J., Campos, Y., Zaitsev, V., Nourse, A., Waddell, B., Lewis, W., Taylor, G., & d'Azzo, A. (2009) · Journal of Biological Chemistry
Lysosomal Storage Disorders ResearchGlycosylation and Glycoproteins Research
Cited by 87
- Verified
Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells
Leimig, T., Mann, L., Martin, M. D. P., Bonten, E., Persons, D., Knowles, J., Allay, J. A., Cunningham, J., Nienhuis, A. W., Smeyne, R., et al. (2002) · Blood
Lysosomal Storage Disorders ResearchVirus-based gene therapy research
Cited by 75
- Verified
Lysosomal Protective Protein/Cathepsin A
Bonten, E. J., Galjart, N. J., Willemsen, R., Usmany, M., Vlak, J. M., & d'Azzo, A. (1995) · Journal of Biological Chemistry
Protease and Inhibitor MechanismsCellular transport and secretion
Cited by 59
- Verified
Targeting macrophages with baculovirus‐produced lysosomal enzymes: implications for enzyme replacement therapy of the glycoprotein storage disorder galactosialidosis
Bonten, E. J., Wang, D., Toy, J. N., Mann, L., Mignardot, A., Yogalingam, G., & d'Azzo, A. (2004) · The FASEB Journal
Lysosomal Storage Disorders ResearchViral Infectious Diseases and Gene Expression in Insects
Cited by 54
- Verified
Lysosomal Neuraminidase
Bonten, E. J., & d'Azzo, A. (2000) · Journal of Biological Chemistry
Glycosylation and Glycoproteins ResearchLysosomal Storage Disorders Research
Cited by 51
- Verified
Short-term, high dose enzyme replacement therapy in sialidosis mice
Wang, D., Bonten, E. J., Yogalingam, G., Mann, L., & d’Azzo, A. (2005) · Molecular Genetics and Metabolism
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 50
- Verified
Preclinical Dose-Finding Study With a Liver-Tropic, Recombinant AAV-2/8 Vector in the Mouse Model of Galactosialidosis
Hu, H., Gomero, E., Bonten, E., Gray, J. T., Allay, J., Wu, Y., Wu, J., Calabrese, C., Nienhuis, A., & d'Azzo, A. (2012) · Molecular Therapy
Lysosomal Storage Disorders ResearchVirus-based gene therapy research
Cited by 37
- Verified
The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis
Rudenko, G., Bonten, E., Hol, W. G. J., & d’Azzo, A. (1998) · Proceedings of the National Academy of Sciences
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 36
- Verified
Synthetic ZFTA fusions pinpoint disordered protein domain acquisition as a mechanism of brain tumorigenesis
Arabzade, A., Shirnekhi, H. K., Varadharajan, S., Ippagunta, S. M., Phillips, A. H., Laboe, N., Baggett, D. W., Wahiduzzaman, Jo, M., Zheng, T., et al. (2025) · Nature Cell Biology
Genomics and Chromatin DynamicsGlioma Diagnosis and Treatment
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free